2017 Form 10-K Financial Statement

#000143774918001990 Filed on February 08, 2018

View on sec.gov

Income Statement

Concept 2017 2016 Q4 2016
Revenue $85.53M $21.63M $82.46M
YoY Change 3.72% 12.36% 7.89%
Cost Of Revenue $59.30M $14.82M $57.35M
YoY Change 3.39% 8.18% 7.99%
Gross Profit $26.23M $6.810M $25.11M
YoY Change 4.48% 22.7% 7.69%
Gross Profit Margin 30.67% 31.48% 30.45%
Selling, General & Admin $15.02M $3.600M $15.40M
YoY Change -2.47% 13.56% 8.19%
% of Gross Profit 57.25% 52.86% 61.33%
Research & Development $4.737M $1.460M $5.946M
YoY Change -20.33% -11.52% 6.12%
% of Gross Profit 18.06% 21.44% 23.68%
Depreciation & Amortization $2.005M $620.0K $2.223M
YoY Change -9.81% -8.82% -7.41%
% of Gross Profit 7.64% 9.1% 8.85%
Operating Expenses $19.76M $5.160M $21.35M
YoY Change -7.44% 5.74% 6.8%
Operating Profit $6.476M $1.650M $3.763M
YoY Change 72.1% 146.27% 13.0%
Interest Expense -$200.0K -$50.00K -$300.0K
YoY Change -33.33% 0.0% 50.0%
% of Operating Profit -3.09% -3.03% -7.97%
Other Income/Expense, Net -$181.0K $30.00K $80.00K
YoY Change -326.25% 0.0% 23.08%
Pretax Income $6.295M $1.630M $3.580M
YoY Change 75.84% 232.65% 13.65%
Income Tax -$1.369M -$120.0K $98.00K
% Of Pretax Income -21.75% -7.36% 2.74%
Net Earnings $7.648M $1.750M $3.509M
YoY Change 117.95% 250.0% 22.31%
Net Earnings / Revenue 8.94% 8.09% 4.26%
Basic Earnings Per Share $0.49 $0.23
Diluted Earnings Per Share $0.48 $114.5K $0.23
COMMON SHARES
Basic Shares Outstanding 15.53K 15.26M
Diluted Shares Outstanding 15.86K 15.41M

Balance Sheet

Concept 2017 2016 Q4 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.20M $10.60M $10.60M
YoY Change 71.7% -26.39% -26.39%
Cash & Equivalents $18.20M $10.71M $10.60M
Short-Term Investments
Other Short-Term Assets $2.700M $2.200M $2.200M
YoY Change 22.73% 4.76% 4.76%
Inventory $26.30M $23.46M $23.50M
Prepaid Expenses
Receivables $14.70M $13.18M $13.20M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $61.90M $49.42M $49.40M
YoY Change 25.3% -4.86% -4.82%
LONG-TERM ASSETS
Property, Plant & Equipment $7.600M $7.999M $8.000M
YoY Change -5.0% -11.5% -11.11%
Goodwill $19.97M
YoY Change 22.61%
Intangibles $7.194M
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $72.00K $200.0K
YoY Change 0.0% -76.7% -33.33%
Total Long-Term Assets $35.30M $35.32M $35.30M
YoY Change 0.0% 19.43% 19.26%
TOTAL ASSETS
Total Short-Term Assets $61.90M $49.42M $49.40M
Total Long-Term Assets $35.30M $35.32M $35.30M
Total Assets $97.20M $84.74M $84.70M
YoY Change 14.76% 3.95% 3.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.800M $7.292M $7.300M
YoY Change 20.55% 12.29% 12.31%
Accrued Expenses $5.300M $3.900M $3.900M
YoY Change 35.9% -4.88% -4.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.20M $11.33M $11.30M
YoY Change 25.66% 4.43% 4.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $18.00K $0.00
YoY Change -35.71%
Total Long-Term Liabilities $0.00 $18.00K $0.00
YoY Change -35.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.20M $11.33M $11.30M
Total Long-Term Liabilities $0.00 $18.00K $0.00
Total Liabilities $18.00M $16.88M $16.70M
YoY Change 7.78% 8.89% 8.44%
SHAREHOLDERS EQUITY
Retained Earnings -$90.54M
YoY Change -3.73%
Common Stock $1.932M
YoY Change 0.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $4.016M
Shareholders Equity $79.20M $68.03M $68.00M
YoY Change
Total Liabilities & Shareholders Equity $97.20M $84.74M $84.70M
YoY Change 14.76% 3.95% 3.93%

Cashflow Statement

Concept 2017 2016 Q4 2016
OPERATING ACTIVITIES
Net Income $7.648M $1.750M $3.509M
YoY Change 117.95% 250.0% 22.31%
Depreciation, Depletion And Amortization $2.005M $620.0K $2.223M
YoY Change -9.81% -8.82% -7.41%
Cash From Operating Activities $7.270M $4.080M $7.653M
YoY Change -5.0% 264.29% -10.49%
INVESTING ACTIVITIES
Capital Expenditures $1.392M -$230.0K $1.219M
YoY Change 14.19% -85.63% -58.11%
Acquisitions $9.857M
YoY Change
Other Investing Activities -$60.00K -$9.860M
YoY Change 500.0%
Cash From Investing Activities -$1.392M -$290.0K -$11.08M
YoY Change -87.43% -81.99% 280.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $607.0K
YoY Change -100.0% -93.53%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.403M 250.0K -175.0K
YoY Change -901.71% -21.88% -98.03%
NET CHANGE
Cash From Operating Activities 7.270M 4.080M 7.653M
Cash From Investing Activities -1.392M -290.0K -11.08M
Cash From Financing Activities 1.403M 250.0K -175.0K
Net Change In Cash 7.624M 4.040M -3.598M
YoY Change -311.9% -2476.47% 11.39%
FREE CASH FLOW
Cash From Operating Activities $7.270M $4.080M $7.653M
Capital Expenditures $1.392M -$230.0K $1.219M
Free Cash Flow $5.878M $4.310M $6.434M
YoY Change -8.64% 58.46% 14.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 ulbi Number Of Shares Due To Dilutive Stock Options Included In Diluted Earnings Per Share Calculation
NumberOfSharesDueToDilutiveStockOptionsIncludedInDilutedEarningsPerShareCalculation
135458
CY2016 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
34000
CY2017 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
11000
CY2017 ulbi Customer Funded Research And Development Expense Included In Cost Of Goods Sold
CustomerFundedResearchAndDevelopmentExpenseIncludedInCostOfGoodsSold
405000
CY2016 ulbi Customer Funded Research And Development Expense Included In Cost Of Goods Sold
CustomerFundedResearchAndDevelopmentExpenseIncludedInCostOfGoodsSold
209000
CY2017 ulbi Defined Contribution Plan Maximum Employee Contribution Percentage Subject To Employer Matching Contribution
DefinedContributionPlanMaximumEmployeeContributionPercentageSubjectToEmployerMatchingContribution
0.04
CY2017 ulbi Effective Income Tax Rate Reconciliation Excess Accrual Percent
EffectiveIncomeTaxRateReconciliationExcessAccrualPercent
CY2016 ulbi Effective Income Tax Rate Reconciliation Excess Accrual Percent
EffectiveIncomeTaxRateReconciliationExcessAccrualPercent
-0.052
CY2017 ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
183000
CY2016 ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
263000
CY2016 ulbi Number Of Dilutive Restricted Stock Units Included In Diluted Earningspersharecalculation
NumberOfDilutiveRestrictedStockUnitsIncludedInDilutedEarningspersharecalculation
15900
CY2017 ulbi Number Of Dilutive Stock Options Included In Diluted Earnings Per Share Calculation
NumberOfDilutiveStockOptionsIncludedInDilutedEarningsPerShareCalculation
1035711
CY2016 ulbi Number Of Dilutive Stock Options Included In Diluted Earnings Per Share Calculation
NumberOfDilutiveStockOptionsIncludedInDilutedEarningsPerShareCalculation
1238804
CY2016 ulbi Number Of Shares Due To Dilutive Restricted Stock Units Included In Diluted Earnings Per Share Calculation
NumberOfSharesDueToDilutiveRestrictedStockUnitsIncludedInDilutedEarningsPerShareCalculation
9538
CY2017 ulbi Number Of Shares Due To Dilutive Stock Options Included In Diluted Earnings Per Share Calculation
NumberOfSharesDueToDilutiveStockOptionsIncludedInDilutedEarningsPerShareCalculation
330676
CY2017 ulbi Provision For Doubtful Accounts Net Of Recoveries
ProvisionForDoubtfulAccountsNetOfRecoveries
-5000
CY2016 ulbi Provision For Doubtful Accounts Net Of Recoveries
ProvisionForDoubtfulAccountsNetOfRecoveries
-24000
CY2017 ulbi Research And Development Expense Gross
ResearchAndDevelopmentExpenseGross
5142000
CY2016 ulbi Research And Development Expense Gross
ResearchAndDevelopmentExpenseGross
6155000
CY2017 ulbi Research And Development Revenue
ResearchAndDevelopmentRevenue
405000
CY2016 ulbi Research And Development Revenue
ResearchAndDevelopmentRevenue
209000
CY2017 ulbi Revenue Total Percentage
RevenueTotalPercentage
CY2016 ulbi Revenue Total Percentage
RevenueTotalPercentage
CY2017 ulbi Sharebased Compensation Arrangement Bysharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementBysharebasedPaymentAwardFairValueAssumptionsForfeitureRate
0.1
CY2016 ulbi Sharebased Compensation Arrangement Bysharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementBysharebasedPaymentAwardFairValueAssumptionsForfeitureRate
0.1
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8787000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7292000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14657000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13179000
CY2017Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
168000
CY2016Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
172000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
59141000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
57194000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1611000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3080000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180211000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
178163000
CY2016 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
676000
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
642000
CY2017 us-gaap Advertising Expense
AdvertisingExpense
26000
CY2016 us-gaap Advertising Expense
AdvertisingExpense
32000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
653000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
710000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
292000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
277000
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
52000
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
71000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
422000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
503000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
824500
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1332281
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15308971
CY2017Q4 us-gaap Assets
Assets
97186000
CY2016Q4 us-gaap Assets
Assets
84744000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
61916000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
49420000
CY2016 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.25
CY2016 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.25
CY2016 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
4061000
CY2016 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
3821000
CY2016 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
82460000
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
87000
CY2016 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
83000
CY2016Q4 us-gaap Cash
Cash
10629000
CY2015Q4 us-gaap Cash
Cash
14393000
CY2017Q4 us-gaap Cash
Cash
18241000
CY2017 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
7612000
CY2016 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-3764000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
946027
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19670928
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19324723
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15651217
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1966000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1932000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9117000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1336000
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">r.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"> </div></div></div> </td> <td> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Concentration Related to Customers and Suppliers</div></div></div> </td> </tr> </table> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">During t<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">he year ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017, </div>we had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> major customer, a large defense primary contractor, which comprised <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> of our revenues in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. During the year ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2016, </div>another large defense primary contractor comprised <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13%</div> of our sales; however, sales to this customer in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> comprised <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3%</div> of our sales. There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> other customers that comprised greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of our total revenues during these years.</div><br /> &nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Currently, we do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experience significant seasonal trends in our revenues. Since a significant portion of our revenues are based on purchases from U.S. and allied country defense departments, the timing of our sales could be impacted by delays in the government budget process and the decisions to deploy resources to support military purchases of our products.</div> <div style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">We generally do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> distribute our products to a concentrated geographical area nor is there a significant concentration of credit risks arising from individuals or groups of customers engaged in similar activities, or who have similar economic characteristics. While direct and indirect sales to the U.S. Department of Defense<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> have been substantial during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> we do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> consider this customer to be a significant credit risk. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> normally obtain collateral on trade accounts receivable.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Certain materials and components used in our products are available only from a single or a limited number of suppliers. As such, some materials and components could become in short supply resulting in limited availability and/or increased costs. Additionally, we <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> may </div>elect to develop relationships with a single or limited number of suppliers for materials and components that are otherwise generally available.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp; Although we believe that alternative suppliers are available to supply materials and components that could replace materials and components currently used and that, if necessary, we would be able to redesign our products to make use of such alternatives, any interruption in the supply from any supplier that serves as a sole source could delay product shipments and have a material adverse effect on our business, financial condition and results of operations.&nbsp; We have experienced interruptions of product deliveries by sole source suppliers in the past.</div></div></div></div>
CY2016Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
170000
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
59299000
CY2017Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
5136000
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
57352000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-70000
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
300000
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
13000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
300000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-37000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
20000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1717000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
220000
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-7000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-85000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1669000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
135000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3844000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5471000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
55000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1535000
CY2016Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2923000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22645000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
33358000
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
9000
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
27000
CY2017Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
32000
CY2016Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
94000
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
32000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
94000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17870000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27127000
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
44000
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
77000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1837000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1704000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1359000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1527000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22636000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
33331000
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3835000
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
5444000
CY2017Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
3806000
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
5471000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3867000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5538000
CY2017Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
38000
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
181000
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
191000
CY2017 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.02
CY2017 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.5
CY2017 us-gaap Depreciation
Depreciation
2005000
CY2016 us-gaap Depreciation
Depreciation
2223000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2427000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2726000
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2017 us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
331000
CY2016 us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
-166000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.218
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.027
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.209
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.308
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.038
CY2016 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.022
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.007
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.096
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.001
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.027
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies Domestic
EffectiveIncomeTaxRateReconciliationTaxContingenciesDomestic
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies Domestic
EffectiveIncomeTaxRateReconciliationTaxContingenciesDomestic
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.009
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.062
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2413000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1258000
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
0
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
385000
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7085000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7194000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10000
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
86000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9259000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8796000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
400000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
334000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
348000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
367000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
379000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16344000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15990000
CY2017 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2016 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-29000
CY2015Q4 us-gaap Goodwill
Goodwill
16283000
CY2016Q4 us-gaap Goodwill
Goodwill
19965000
CY2017Q4 us-gaap Goodwill
Goodwill
20458000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1369000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98000
CY2017 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-1939000
CY2016 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-805000
CY2017 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
493000
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017 us-gaap Gross Profit
GrossProfit
26232000
CY2016 us-gaap Gross Profit
GrossProfit
25108000
CY2017 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">l.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"> </div></div></div> </td> <td> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Warranty Reserves</div></div></div> </td> </tr> </table> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">We estimate future costs associated with expected product failure rates, material usage and service costs in the development of our warranty obligations. Warranty reserves, included in other current liabilities and other long-term liabilities as applicable on our Consolidated Balance Sheets, are based on historical experience of warranty claims. In the event the actual results of these items differ from the estimates, an adjustment to the warranty obligation would be recorded.</div></div></div>
CY2017 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2016 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
4831000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2803000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6295000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3580000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1464000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
777000
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
345000
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
273000
CY2017 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
2661000
CY2016 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-1362000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1295000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
667000
CY2017 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1669000
CY2016 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-135000
CY2017 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-8000
CY2016 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-158000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2537000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1981000
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
673000
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-730000
CY2017 us-gaap Interest And Debt Expense
InterestAndDebtExpense
183000
CY2016 us-gaap Interest And Debt Expense
InterestAndDebtExpense
263000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
102000
CY2016 us-gaap Interest Paid Net
InterestPaidNet
179000
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9707000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7988000
CY2017Q4 us-gaap Inventory Net
InventoryNet
26326000
CY2016Q4 us-gaap Inventory Net
InventoryNet
23456000
CY2017Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
14606000
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
14482000
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2013000
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
986000
CY2017Q4 us-gaap Liabilities
Liabilities
18137000
CY2016Q4 us-gaap Liabilities
Liabilities
16884000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97186000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84744000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14239000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11328000
CY2015Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
42000000
CY2017Q4 us-gaap Minority Interest
MinorityInterest
-154000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
660000
CY2016Q4 us-gaap Minority Interest
MinorityInterest
-170000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1403000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-175000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1392000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11076000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7270000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7653000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
7648000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
3509000
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16000
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-27000
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2017 us-gaap Operating Expenses
OperatingExpenses
19756000
CY2016 us-gaap Operating Expenses
OperatingExpenses
21345000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
6476000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
3763000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
558000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
100000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
416000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
668000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
125000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72000
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1469000
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2173000
CY2017Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
7085000
CY2016Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
7194000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2871000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2606000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
80000
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
607000
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
26000
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
28000
CY2017 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9857000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1392000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1219000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2603000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2079000
CY2017 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">d.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div></div> </td> <td> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Reclassifications</div></div></div> </td> </tr> </table> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Certain items previously reported in specific financial statement captions <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">are reclassified to conform to the current presentation. There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> material reclassifications for the years ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div></div></div>
CY2017 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
CY2016 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
3030000
CY2017 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
CY2016 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-3030000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1429000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
460000
CY2016Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
172000
CY2015Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
192000
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
149000
CY2017 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
107000
CY2016 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
59000
CY2017 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
84000
CY2016 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
39000
CY2017 us-gaap Profit Loss
ProfitLoss
7664000
CY2016 us-gaap Profit Loss
ProfitLoss
3482000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
66711000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65193000
CY2017 us-gaap Property Plant And Equipment Gross Period Increase Decrease
PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease
1290000
CY2016 us-gaap Property Plant And Equipment Gross Period Increase Decrease
PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease
1377000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7570000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7999000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4737000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5946000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
89000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
77000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82894000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90542000
CY2017 us-gaap Revenues
Revenues
85531000
CY2016 us-gaap Revenues
Revenues
82460000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
588000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15019000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15399000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
653000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
710000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.482
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.014
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1045798
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1302390
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.05
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
149000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
374815
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
151149
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
244750
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
369550
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.47
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.01
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2624000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2323581
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1860211
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2257969
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.22
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.06
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.30
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1806000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.63
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2438000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1649594
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.29
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.86
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.11
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.09
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.60
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.69
CY2017 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
3.22
CY2017Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1045798
CY2017Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1860211
CY2017 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
15
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y292D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y229D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y339D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y273D
CY2017Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
4.18
CY2017Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
5.06
CY2017 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y339D
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
333305
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
152789
CY2016 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
460000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1429000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
79203000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
68030000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
79049000
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
67860000
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
66016000
CY2016 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-2173000
CY2017 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
1469000
CY2017Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
18469000
CY2016Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
18443000
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4019711
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4015752
CY2016 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
156092
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2592095
CY2016 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
635000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10480000
CY2017 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
26000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">c.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"> </div></div></div> </td> <td> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Management's Use of Judgment and Estimates </div></div></div> </td> </tr> </table> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at year end and the reported amounts of revenues and expenses during the reporting period. Key areas affected by estimates include: (a) carrying value of goodwill and intangible assets; (b) reserves for deferred tax assets, excess and obsolete inventory, warranties, and bad debts; (c) <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">valuation of assets acquired and liabilities assumed in business combinations; (d) various expense accruals; and (e) stock-based compensation. Our actual results could differ from these estimates. </div></div></div></div>
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-10695000
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1262000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15858000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15405000
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15528000
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15261000

Files In Submission

Name View Source Status
0001437749-18-001990-index-headers.html Edgar Link pending
0001437749-18-001990-index.html Edgar Link pending
0001437749-18-001990.txt Edgar Link pending
0001437749-18-001990-xbrl.zip Edgar Link pending
ex_104232.htm Edgar Link pending
ex_104233.htm Edgar Link pending
ex_104234.htm Edgar Link pending
ex_104235.htm Edgar Link pending
ex_104236.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ulbi-20171231.xml Edgar Link completed
ulbi-20171231.xsd Edgar Link pending
ulbi-20171231_cal.xml Edgar Link unprocessable
ulbi-20171231_def.xml Edgar Link unprocessable
ulbi-20171231_lab.xml Edgar Link unprocessable
ulbi-20171231_pre.xml Edgar Link unprocessable
ulbi20171231_10k.htm Edgar Link pending